The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2.
Joanna Szkandera
No relevant relationships to disclose
Gudrun Absenger
No relevant relationships to disclose
Melanie Weissmueller
No relevant relationships to disclose
Martin Pichler
No relevant relationships to disclose
Michael Stotz
No relevant relationships to disclose
Sigurd Lax
No relevant relationships to disclose
Gerhard Leitner
No relevant relationships to disclose
Martin Asslaber
No relevant relationships to disclose
Wilfried Renner
No relevant relationships to disclose
Armin Gerger
No relevant relationships to disclose